Mercado fechará em 2 h 45 min

Moderna, Inc. (M1RN34.SA)

São Paulo - São Paulo Preço Adiado. Moeda em BRL.
Adicionar à lista
61,53-1,98 (-3,12%)
A partir de 01:56PM BRT. Mercado aberto.

Moderna, Inc.

200 Technology Square
Cambridge, MA 02139
United States
617 714 6500
https://www.modernatx.com

Setor(es)Healthcare
IndústriaBiotechnology
Funcionários Integrais3.400

Principais Executivos

NomeTítuloPagarExercidoNascido em
Dr. Noubar B. Afeyan Ph.D.Co-Founder, Independent Non Exec. Chairman & Member of Technology Advisory Board1,12MN/A1963
Mr. Stephane BancelCEO & Director3,16MN/A1973
Dr. Stephen Hoge M.D.Pres1,8M165,87M1976
Ms. Shannon Thyme KlingerChief Legal Officer & Corp. Sec.1,76MN/A1971
Mr. Juan AndresChief Technical Operations & Quality Officer1,6M194,29M1965
Mr. James M. MockChief Financial OfficerN/AN/A1977
Dr. John V. W. Reynders Ph.D.Chief Information OfficerN/AN/AN/A
Dr. Melissa J. Moore Ph.D.Chief Scientific Officer & Member of Scientific Advisory BoardN/AN/AN/A
Ms. Lavina Talukdar CFASr. VP & Head of Investor RelationsN/AN/AN/A
Colleen HusseySr. Director of Corp. CommunicationsN/AN/AN/A
Os valores são a partir de 31 de dezembro de 2021, e os valores de compensação são relativos ao ano fiscal terminando naquela data. O pagamento é salário, bônus, etc. Exercido é o valor de opções exercidas durante o ano fiscal. Moeda em BRL.

Descrição

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Governança Corporativa

O QualityScore de governança da ISS da Moderna, Inc. a partir de 1 de outubro de 2022 é 10. As principais pontuações para Auditoria são: 9; Conselho: 10; Direitos de Acionistas: 10; Compensação: 9.

Pontuações em governança corporativa são cortesia da Institutional Shareholder Services (ISS). As pontuações indicam a posição do decil em relação ao índice ou à região. Uma decil com pontuação 1 indica menor risco de governança, enquanto uma pontuação 10 indica um maior risco de governança.